ArticleCureus2026
The Use and Perceptions of AI Chatbots in Medical Research: An International Cross-Sectional Survey.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Artificial Intelligence (AI) has undergone remarkable progress, leading to the development of advanced large language models (LLMs). Despite these LLMs' growing adoption, concerns persist regarding the scientific accuracy of AI-generated content, and their acceptance within academic publishing remains contentious. This study aimed to describe AI-chatbot use patterns and to assess medical researchers' perceptions of impact on research credibility, ethical concerns, guideline awareness, and disclosure of future intentions. Methodology A cross-sectional survey-based study spread into Saudi Arabia, Nigeria, Tunis, and England from 2023 to 2024 surveyed researchers, excluding non-medical and non-publishing researchers. Results We analyzed 434 respondents; 175 (40.3%) reported AI-chatbot use. Use varied by country (32.8%-45.9%), but neither gender nor country was significantly associated with use. Older age and more senior roles were associated with lower odds of use (odds ratio (OR): ages 41-50 years, 0.32; residents, 0.31; consultants, 0.17;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.